Law-ref.org
REACH - Registration, Evaluation and Authorisation of Chemicals
Site search
Global links
homepage
documents
Sister sites
Chess-Ref
ZVON
RFC-Ref
InChI
REACH Online
Local links
Previous
Next
Frontpage
Contents
Keywords
Local
Global
REACH - Registration, Evaluation and Authorisation of Chemicals
TITLE-VI
: EVALUATION
CHAPTER-1
: Dossier evaluation
ARTICLE 40
:
Examination
of
testing
proposals
ARTICLE 40:
Examination
of
testing
proposals
1. The
Agency
shall examine any
testing
proposal
set out in a
registration
or a
downstream user
report
for
provision
of the
information
specified in
Annexes
IX and X for a
substance
.
Priority
shall be given to registrations of
substances
which have or may have PBT, vPvB, sensitising and/or
carcinogenic
,
mutagenic
or
toxic
for
reproduction
(CMR) properties, or
substances
classified as
dangerous
according to Directive 67/548/EEC above 100 tonnes per
year
with uses resulting in widespread and diffuse
exposure
.
2.
Information
relating to
testing
proposals
involving
tests
on
vertebrate animals
shall be
published
on the
Agency
website. The
Agency
shall
publish
on its website the
name
of the
substance
, the
hazard
end-point for which vertebrate
testing
is proposed, and the
date
by which any
third party
information
is required. It shall invite
third parties
to submit, using the format provided by the
Agency
,
scientifically
valid
information
and
studies
that
address
the
relevant
substance
and
hazard
end-point, addressed by the
testing
proposal
, within 45
days
of the
date
of
publication
. All such
scientifically
valid
information
and
studies
received
shall be taken into
account
by the
Agency
in preparing its
decision
in
accordance
with paragraph 3.
3. On the basis of the
examination
under paragraph 1, the
Agency
shall
draft
one of the following
decisions
and that
decision
shall be taken in
accordance
with the
procedure
laid down in
Articles
50
and
51
:
(a) a
decision
requiring the
registrant
(s) or
downstream user
(s)
concerned
to carry out the proposed
test
and setting a deadline for submission of the
study
summary
, or the robust
study
summary
if required by Annex I;
(b) a
decision
in
accordance
with point (a), but modifying the
conditions
under which the
test
is to be carried out;
(c) a
decision
in
accordance
with points (a), (b) or (d) but requiring
registrant
(s) or
downstream user
(s) to carry out one or more additional
tests
in
cases
of
non-compliance
of the
testing
proposal
with
Annexes
IX, X and XI;
(d) a
decision
rejecting the
testing
proposal
;
(e) a
decision
in
accordance
with points (a), (b) or (c), if several
registrants
or
downstream users
of the same
substance
have submitted
proposals
for the same
test
, giving them the
opportunity
to reach an
agreement
on who will perform the
test
on behalf of all of them and to inform the
Agency
accordingly within 90
days
. If the
Agency
is not informed of such
agreement
within such 90
days
, it shall
designate
one of the
registrants
or
downstream users
, as appropriate, to perform the
test
on behalf of all of them.
4. The
registrant
or
downstream user
shall submit the
information
required to the
Agency
by the deadline set.
[
Next page
]
Referred by:
ARTICLE 22
: Further
duties
of
registrants
ARTICLE 42
: Check of
information
submitted and follow-up to
dossier
evaluation
ARTICLE 43
:
Procedure
and
time
periods
for
examination
of
testing
proposals
ARTICLE 50
:
Registrants
' and
downstream users
'
rights
ARTICLE 51
:
Adoption
of
decisions
under
dossier
evaluation